Hope for rare brain disease: new drug trial targets movement and daily life
NCT ID NCT05163288
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called N-acetyl-L-leucine (IB1001) in people aged 4 and older with Niemann-Pick disease type C, a rare genetic disorder that affects movement and thinking. The trial compares the drug to a placebo to see if it improves coordination and quality of life. After the main study, participants can receive the drug for up to 3 more years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NIEMANN-PICK DISEASE, TYPE C are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Amsterdam UMC
RECRUITINGAmsterdam, 1105, Netherlands
Contact Email: •••••@•••••
Contact
-
Comenius University in Bratislva
ACTIVE_NOT_RECRUITINGBratislava, 833 40, Slovakia
-
First Faculty of Medicine, Charles University Hospital Prague
ACTIVE_NOT_RECRUITINGPrague, 128 08, Czechia
-
Great Ormond Street Hospital
ACTIVE_NOT_RECRUITINGLondon, WC1N 3JH, United Kingdom
-
Ludwig Maximilian University of Munich
NOT_YET_RECRUITINGMünchen, 80539, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mayo Clinic
COMPLETEDRochester, Minnesota, 55905, United States
-
Royal Free London NHS Foundation Trust
ACTIVE_NOT_RECRUITINGLondon, United Kingdom
-
Royal Manchester Children's Hospital
ACTIVE_NOT_RECRUITINGManchester, M13 9WL, United Kingdom
-
SphinCS - Institute of Clinical Science in Lysosomal Storage Disorders
ACTIVE_NOT_RECRUITINGHöchheim, 65239, Germany
-
The Royal Melbourne Hospital
ACTIVE_NOT_RECRUITINGParkville, Victoria, 3050, Australia
-
University Hospital Bern Inselspital
ACTIVE_NOT_RECRUITINGBern, 3010, Switzerland
-
University Hospital Münster
ACTIVE_NOT_RECRUITINGMünster, 48149, Germany
-
University of Giessen
ACTIVE_NOT_RECRUITINGGiessen, 35389, Germany
-
University of Hamburg
COMPLETEDHamburg, 20246, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New pill shows promise for rare brain disorders in early trial
- Promising drug tested for rare liver disease in newborns
- Search for NPC clues could speed future treatments
- Scientists dive into rare cholesterol disorders to uncover clues
- New study aims to crack the code of rare brain disease
- New york program offers extra screening for 100,000 newborns